Business

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales Performance in U.S. Retail in H1 2025 and Expands Its Digital Footprint in Q2 Company Launches an Exploration of Strategic Alternatives to Enhance Shareholder Value Company Postpones H1 2025 Earnings Release and Conference Call; Provides Update to FY 2025 Guidance LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE)

articleWaldencast PlcAugust 18, 202516/company/waldencast-acquisition-corp/news/waldencast-announces-strong-progress-business-214300206
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

About this update from Waldencast Plc

[{"type":"image","alt":"Waldencast plc","displaySize":"","headline":null,"caption":"Waldencast plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":37,"url":"https://media.zenfs.com/en/globenewswire.com/21d8976473fad764236ddecc2f0e6a18"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/O8XxKiX8breN2u.EyGywfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUyO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/21d8976473fad764236ddecc2f0e6a18","width":300,"height":37}},"lazy":false},{"type":"text","content":"Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S.","length":155,"tagName":"p"},{"type":"text","content":"Milk Makeup Delivers Strong Retail Sales Performance in U.S. Retail in H1 2025 and Expands Its Digital Footprint in Q2","length":118,"tagName":"p"},{"type":"text","content":"Company Launches an Exploration of Strategic Alternatives to Enhance Shareholder Value","length":86,"tagName":"p"},{"type":"text","content":"Company Postpones H1 2025 Earnings Release and Conference Call; Provides Update to FY 2025 Guidance","length":99,"tagName":"p"},{"type":"text","content":"LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today provided a business update for H1 2025 results.","length":209,"tagName":"p"},{"type":"text","content":"“Our brands saw accelerating revenue growth in the second quarter and we delivered significant progress against our strategic priorities while making important investments to support our future, thus capping off a highly productive first half for the Company,” said Michel Brousset, Co-Founder and CEO of Waldencast plc. “In Q2, we resumed revenue growth, as we cycled the anniversary of last year’s exceptionally strong launches that weighed on Q1 comparisons.","length":461,"tagName":"p"},{"type":"text","content":"Milk Makeup sell-out performance in the U.S. accelerated to the high-20s, through the roll-out at Ulta Beauty and the launch in Amazon Premium Beauty, while continuing to deliver blockbuster innovations like Hydro Grip Gel Skin Tint and Balmade Electrolyte Lip Balm. This strong performance domestically was dampened by challenges in international markets where consumption was soft and we ...

More updates from Waldencast Plc

Obagi MedicalUlta BeautyThe CompanyMilk Makeuprevenue growthinternational marketsdistribution channelsAmazon Premium BeautyCompanyperformance